Table 1.

Descriptive Characterization of Patients' Clinical and Socio-Demographic Variables. in Relation to the Presence or Absence of Disease Recurrence

			Recurrence(n/%)
	n	%	Without recurrence	With recurrence	p
Race
Mixed/brown	31	79.5	26 (81.3)	5 (71.4)	0.617
White	8	20.5	6 (18.8)	2 (28.6)
Age
≤60 years	20	51.3	17 (53.1)	3 (42.9)	0.695
≥60 years	19	48.7	15 (46.9)	4 (57.1)
Marital status
Unmarried	18	46.6	9 (28.1)	4 (57.1)	0.194
Married	21	53.8	23 (71.9)	3 (42.9)
Origin
Metropolitan region	18	46.2	15 (46.9)	3 (42.9)	1
Countryside	21	53.8	17 (53.1)	4 (57.1)
Educational level
Primary	22	56.4	19 (59.4)	3 (42.9)	0.677
Higher education	17	53.8	13 (40.6)	4 (57.1)
Health care coverage
SUS	35	92.1	30 (93.8)	5 (83.3)	0.412
Private health insurance	3	7.9	2 (6.3)	1 (16.7)
Treatment
Surgery + RT	1	2.6	1 (3.1)	0 (0.0)	0.333
Surgery + CT	7	17.9	7 (21.9)	0 (0.0)
Surgery + RT + CT	31	79.5	24 (75.0)	7 (100.0)
N
N0	7	17.9	6 (18.8)	1 (14.3)	0.886
N1	12	30.8	9 (28.1)	3 (42.9)
N2	8	20.5	7 (21.9)	1 (14.3)
N3	12	30.8	10 (31.3)	2 (28.6)
M*
MX	36	94.7	30(96.8)	6 (85.7)	0.339
M1	2	5.3	1 (3.2)	1 (14.3)
ki 67*
≤25%	17	48.6	14 (48.3)	3 (50.0)	1
≥ 25%	18	51.4	15 (51.7)	3 (50.0)
Immunochemistry profile					-
RE +	37	97.4	-	-
RP +	34	87.2	-	-
HER2 +	10	26.3	-	-
Phenotype*
Luminal A	10	26.3	9 (29.0)	1 (14.3)	0.65
Luminal B	28	73.7	22 (71.0)	6 (85.7)
Disease-free survival
Without recurrence	32	82.1	-	-	-
With recurrence	7	17.9	-	-
Survival
Alive	37	94.9	-	-	-
Dead	2	5.1	-	-

Pearson's chi-square test or Fisher's exact test, p<0,05. RT, radiotherapy; CT, chemotherapy